世界のがんナノ医療市場 – 業界動向と2030年までの予測

 がんナノ医療市場の分析と規模

国際がん研究機関によると、2020年には全世界で1,030万人ががんで死亡し、1,930万人が新たにがんを発症すると予想されています。さらに、2040年までに1,640万人ががん関連の原因で死亡し、毎年2,950万人が新たにがんと診断されると予想されています。ナノ医療がますます注目されている主な理由の1つは、がんや心血管疾患などの慢性疾患の罹患率の上昇です。さらに、高血圧、肥満、その他の心血管疾患の患者数の増加などにより、がんナノ医療の市場は拡大しています。

データブリッジ市場調査は、2022年に1,800億米ドルであったがんナノ医療市場は、2023年から2030年の予測期間中に12％のCAGRで成長し、2030年までに4,456.7億米ドルに達すると予測しています。データブリッジ市場調査がまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

がんナノ医療市場の範囲とセグメンテーション  

Market Definition

Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the market, while the remaining 122 are in clinical trials, either in Phase II or Phase III trials.

Global Cancer Nanomedicine Market Dynamics

Drivers

• New product launches

Nanotechnology-based liposome products may be considered one of the most advanced segments of oncology medications. For instance, Ortho Pharmaceuticals' Doxil was one of the first cancer nanomedicines approved by the US FDA in 1995 for treating AIDS-related Kaposi's sarcoma. DaunoXome by Galen Ltd is a liposomal formulation used to treat HIV-related Kaposi sarcoma, and clinical trials for this medicine in leukaemia are also being conducted. More products are in various stages of clinical trials and will be introduced into the global market in the coming years.

• Usage of nanoparticle-based imaging agents

Because of their small size, nanoparticles are easily absorbed by cells and researchers used this property to aid in disease diagnosis. Oncologists can gain a better understanding of tumour shape and size, as well as precise location, for better treatment. A few nanoparticle-based imaging agents on the market are used for Magnetic Resonance (MR) imaging. SPIO nanoparticles used in imaging include Endorem by Guerbet, Resovist by Bayer, and Feridex by Berlex Laboratories. Aside from oncology, they are also used to diagnose cardiovascular and neurological diseases, propelling the market's growth.

Opportunities

• Increasing Demand for Nanomedicines

The growing demand for nanomedicines can be attributed to the rapidly expanding applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems. The rise in cancer and cardiovascular disease incidences has boosted demand for nanomedicines, resulting in increased public and private investment in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side effects of these therapies are also major drivers of the cancer nanomedicine industry's growth.

Restraints/Challenges

• Side effects associated with the consumption of nanoparticles

The low rate of adoption, the increasing side effects associated with the consumption of nanoparticles, and the stringent regulatory framework for drug approvals are acting as market restraints for the growth of the cancer nanomedicine market during the forecast period.

This cancer nanomedicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cancer nanomedicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Cancer Nanomedicine Market

According to reports, COVID-19 positively impacts the cancer nanomedicine market. This was due to increased demand for nanomedicines to treat medical conditions similar to cancer. Furthermore, nanomedicine applications opened up new avenues for the development of innovative solutions for the prevention, detection, and treatment of viral diseases such as the COVID-19 virus, boosting the growth of the cancer nanomedicine industry. The active involvement of well-established pharmaceutical companies in the development of novel Nano science-based therapeutics is expected to influence market growth. Furthermore, advances in nanotechnology and its expanding applications in preventive interventions, early disease diagnosis, chronic and acute disorder prevention, and acute and chronic disorder prophylaxis of acute as well as chronic disorders are the factors expected to drive the cancer nanomedicine industry growth.

Recent developments

• In 2021, The national nanotechnology effort received more than USD 1.7 billion in funding from the US government, highlighting the importance of nanotechnology. Furthermore, Forbes ranks nanotechnology as the sixth most important growth technology to watch over the next ten years.

Global Cancer Nanomedicine Market Scope

The cancer nanomedicine market is segmented on the basis of type, agent type, mechanism, cancer type, imaging technique, and phase. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Inorganic Nanoparticles
• Synthesis of gold nanoparticle
• Organic Nanoparticles
• Polymeric nanoparticle
• lipid organic nanoparticles

 Agent Type

• Diagnostic Agents
• Cancer biomarkers
• Diagnostic device
• Biosensors
• Microarrays
• Nanoprobes
• Quantum dots
• Therapeutic Agents
• Photodynamic therapy
• Photo thermal therapy
• Drug Delivery Agents

 Mechanism

• Targeting Tumor Cells
• Passive targeting
• Active targeting
• Nanocarrier - Drug Complex
• Liposomes
• Dendrimers
• Micelles
• Inorganic nanocarriers
• Drug Release Systems

Cancer Type

• Breast Cancer
• Pancreatic Cancer
• Brain Cancer
• Lung Cancer
• Others

 Imaging Technique

• Positron Emission Tomography
• Single Photon Emitted Tomography
• Magnetic Resonance Imaging (MRI)

 Phase

• Research
• Preclinical
• Phase-I
• Phase-I/II
• Phase-II
• Phase-III

Cancer Nanomedicine Market Regional Analysis/Insights

The cancer nanomedicine market is analyzed and market size insights and trends are provided by country, type, agent type, mechanism, cancer type, imaging technique, and phase as referenced above.

The countries covered in the cancer nanomedicine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cancer nanomedicine market due to the growing number of research and development activities along with the prevalence of various start-ups organizations.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the surging levels of investment for research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Cancer Nanomedicine Market Share Analysis

The cancer nanomedicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cancer nanomedicine market.

Some of the major players operating in the cancer nanomedicine market are:

• Alnylam Pharmaceuticals, Inc. (U.S.)
• Amgen Inc. (U.S.)
• Arrowhead Pharmaceuticals, Inc. (U.S.)
• AstraZeneca (U.K.)
• Cadila Pharmaceuticals (India)
• CELGENE CORPORATION (U.S.)
• Celsion Corporation (U.S.)
• Genzyme (U.S.)
• Merck & Co., Inc. (U.S.)
• Nippon Kayaku Co.Ltd. (Japan)
• Nanobiotix (France)
• Pfizer Inc. (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Takeda Pharmaceutical Company Limited (Japan)
• General Electric (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Gilead Sciences, Inc. (U.S.)
• Novartis AG (Switzerland)

Research Methodology: Global Cancer Nanomedicine Market

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせ内容をドロップダウンしてください。

DBMR リサーチ チームが使用する主要なリサーチ手法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これ以外にも、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。リサーチ手法について詳しくは、お問い合わせフォームから当社の業界の専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合ったデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、再開発市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社を必要なだけ追加し、必要な形式とデータ スタイルでデータを作成できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクトブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。 

SKU-56752